PRESS RELEASE published on 06/03/2024 at 22:15, 3 months 16 days ago Communiqué de presse : ASCO : Sarclisa, en association avec un protocole VRd, est le premier anti-CD38 permettant d’améliorer significativement la survie sans progression des patients […] Sarclisa associé à VRd améliore la survie sans progression chez les patients atteints de myélome multiple non éligibles à une transplantation, selon l'étude IMROZ publiée dans NEJM Myélome Multiple Sarclisa VRd Patients Non Éligibles Étude IMROZ
BRIEF published on 05/31/2024 at 12:05, 3 months 19 days ago Sanofi Launches 2024 Global Employee Stock Purchase Plan Financial Investment Sanofi Employee Stock Purchase Plan Action 2024 Global Participation
BRIEF published on 05/31/2024 at 12:05, 3 months 19 days ago Sanofi lance un plan mondial d'achat d'actions pour les salariés en 2024 Investissement Financier Sanofi Plan D'achat D'actions Pour Les Salariés Actions 2024 Participation Mondiale
PRESS RELEASE published on 05/31/2024 at 12:00, 3 months 19 days ago Communiqué de presse : Sanofi lance son plan mondial 2024 d’actionnariat salarié Sanofi lance son plan mondial 2024 d'actionnariat salarié, ouvert à 80 000 salariés dans 56 pays, offrant actions à 72,87 € avec décote de 20%. Conditions et dates clés précisées pour la souscription Actionnariat Salarié Souscription Sanofi Plan 2024 Entreprise De Santé
PRESS RELEASE published on 05/31/2024 at 12:00, 3 months 19 days ago Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
BRIEF published on 05/31/2024 at 07:10, 3 months 19 days ago CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD Sanofi COPD Dupixent CHMP Supply
BRIEF published on 05/31/2024 at 07:10, 3 months 19 days ago Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO Sanofi BPCO Dupixent CHMP Approvisionnement
PRESS RELEASE published on 05/31/2024 at 07:05, 3 months 19 days ago Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD European Medicines Agency's CHMP recommends Dupixent for EU approval to treat uncontrolled COPD with raised blood eosinophils. If approved, it would be the first targeted therapy for COPD in the EU Dupixent CHMP EU Approval COPD Treatment Type 2 Inflammation
PRESS RELEASE published on 05/31/2024 at 07:05, 3 months 19 days ago Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO. Dupixent deviendrait la première thérapie ciblée pour la BPCO en Europe Traitement Approbation BPCO Dupixent CHMP
BRIEF published on 05/30/2024 at 15:06, 3 months 20 days ago Sanofi finalise l’acquisition d’Inhibrx, Inc. Acquisition Sanofi Maladies Rares Inhibrx SAR447537
Published on 09/20/2024 at 02:00, 1 hour 40 minutes ago Academy of Math and Science Celebrates Hispanic Heritage Month
Published on 09/19/2024 at 23:15, 4 hours 25 minutes ago Cypher Metaverse Inc. Announces Second Closing of Financing
Published on 09/19/2024 at 23:00, 4 hours 40 minutes ago WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Published on 09/19/2024 at 23:00, 4 hours 40 minutes ago Cerrado Files NI 43-101 Preliminary Economic Assessment Technical Report and Mineral Resource Estimate for The Minera Don Nicolas Mine in Santa Cruz, Argentina
Published on 09/19/2024 at 21:09, 6 hours 30 minutes ago EQS-Adhoc: Mercedes-Benz Group AG adjusts full-year guidance for the year 2024 based on current market outlook
Published on 09/19/2024 at 18:44, 8 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/19/2024 at 18:03, 9 hours 37 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/19/2024 at 17:52, 9 hours 48 minutes ago PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Published on 09/19/2024 at 17:52, 9 hours 48 minutes ago PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Published on 09/19/2024 at 17:45, 9 hours 55 minutes ago Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Published on 09/19/2024 at 17:45, 9 hours 55 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Published on 09/19/2024 at 17:45, 9 hours 55 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)